|
|
T2 Biosystems Announces First Quarter 2022 Financial Results
|
|
|
T2 Biosystems Announces Receipt of Nasdaq Delisting Notice
|
|
|
T2 Biosystems Announces Formation and Members of Scientific Advisory Board
|
|
|
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
|
|
|
T2 Biosystems to Report First Quarter 2022 Financial Results on May 5, 2022
|
|
|
T2 Biosystems Reports Granting of Inducement Award
|
|
|
T2 Biosystems Announces BARDA Exercise of Contract Option 2B Valued at $4.4 Million
|
|
|
T2 Biosystems to Host Analyst and Investor Day on April 12, 2022
|
|
|
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
|
|
|
T2 Biosystems Announces Commercial Expansion Through Distributors in Norway, Finland and Türkiye
|
